Ningbo Menovo Pharmaceutical Co Ltd
603538
Company Profile
Business description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Contact
No.999,Yangfan Road
Room 1406, No.1
High-tech Zone
Ningbo315040
CHNT: +86 57487357091
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
2,353
Stocks News & Analysis
stocks
The ASX's most shorted stocks
The stocks where investors have lost faith and taken active bets against their success, and our analysts’ thoughts on the stocks.
stocks
Should you snap up shares in this volatile ASX player?
After a delayed earnings release and a turbulent regulatory environment, this entertainment behemoth remains a controversial choice for investors.
stocks
Have these dogs of the ASX fallen too far?
Some of the ASX's worst recent performers now look cheap versus our Fair Value estimate. Others still look expensive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,443.70 | 35.30 | -0.42% |
| CAC 40 | 7,521.32 | 54.70 | -0.72% |
| DAX 40 | 19,066.47 | 37.63 | -0.20% |
| Dow JONES (US) | 42,080.37 | 126.13 | 0.30% |
| FTSE 100 | 8,190.61 | 113.01 | -1.36% |
| HKSE | 20,926.79 | 2,172.99 | -9.41% |
| NASDAQ | 18,182.92 | 259.01 | 1.45% |
| Nikkei 225 | 38,937.54 | 395.20 | -1.00% |
| NZX 50 Index | 12,589.72 | 33.73 | 0.27% |
| S&P 500 | 5,751.13 | 55.19 | 0.97% |
| S&P/ASX 200 | 8,176.90 | 28.50 | -0.35% |
| SSE Composite Index | 3,489.78 | 153.28 | 4.59% |